Tenderwize
Back to tender search

Dornase alfa Discount Contract

Techniker Krankenkasse·Hamburg, Germany·Deadline Dec 29, 2026 · 133 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2024-12 - Dornase alfa

70/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

70 / 100

Complexity

30 / 100

Risk factors

Failure to provide correct self-declaration or meet authorization requirements leads to exclusion.

Initial deadline for January 2025 inclusion is very short (2 Dec 2024).

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Dec 2026
  • Conclusion of discount contracts for Dornase alfa under §130a Abs. 8 SGB V
  • Open-House procedure with standardized terms and individual negotiation
Show full summary

Open-House procedure for discount contracts (Rabattverträge) for the active substance Dornase alfa. Contracting parties: Techniker Krankenkasse and HEK. Contract duration up to 24 months (01.01.2025 to 31.12.2026). Open to all eligible pharmaceutical entrepreneurs. No exclusivity, no negotiation of individual terms.

Risks

Failure to provide correct self-declaration or meet authorization requirements leads to exclusion.

Initial deadline for January 2025 inclusion is very short (2 Dec 2024).

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as per §4 Abs. 18 AMG
  • Must hold a valid marketing authorization for Dornase alfa in Germany
  • Must be located in EU/EEA

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Dornase alfa Discount Contract

Conclusion of discount contracts for medicinal products with active substance Dornase alfa under the Open-House procedure.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Dec 2024 - Dec 2026

Category

Pharmaceutical products

Deadline

Deadline Dec 29, 2026

Procurement Details

Publication date
17 Nov 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
702179-2024

Documents (1)

Similar tenders